Pneumonia, Pneumococcal Therapeutic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Pneumonia, Pneumococcal Therapeutic Market is segmented By Route of Administration (Oral, Intravenous, Subcutaneous, Parenteral, Topical), By Molecule Type (Recombinant Fusion Proteins, Small Molecule, Monoclonal Antibody, Peptide Polymer, Gene Therapy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Pneumonia, Pneumococcal Therapeutic Market is segmented By Route of Administration (Oral, Intravenou...

Competitive overview of Pneumonia, Pneumococcal Therapeutic Market

The major players operating in the Pneumonia, Pneumococcal Therapeutic Market include Biotest AG, Vaxcyte, Inc., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc., Sanofi, Johnson & Johnson, Astellas Pharma Inc., CSL Limited, Mitsubishi Tanabe Pharma Corporation, Bavarian Nordic, and SutroVax, Inc.